Immediate and One-Year Outcomes of an Asthma-Tailored Pulmonary Rehabilitation Programme in Overweight and Obese People with Difficult-to-Treat Asthma

Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants...

Full description

Saved in:
Bibliographic Details
Published inJournal of asthma and allergy Vol. 17; pp. 911 - 928
Main Authors Ricketts, Helen, Sharma, Varun, Steffensen, Femke, Mackay, Elaine, MacDonald, Gordon, Buchan, Duncan, Lean, Michael, Chaudhuri, Rekha, Cowan, Douglas
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.01.2024
Dove
Dove Medical Press
Subjects
Online AccessGet full text
ISSN1178-6965
1178-6965
DOI10.2147/JAA.S466894

Cover

Abstract Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥25 kg/m , and identify response predictors. A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year. Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/m . At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7), <0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2), <0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2), <0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive. Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit.
AbstractList Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥25 kg/m , and identify response predictors. A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year. Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/m . At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7), <0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2), <0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2), <0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive. Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit.
Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥25 kg/m2, and identify response predictors.IntroductionManagement of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥25 kg/m2, and identify response predictors.A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year.MethodsA prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year.Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/m2. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7), p<0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2), p<0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2), p<0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive.ResultsOf 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/m2. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7), p<0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2), p<0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2), p<0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive.Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit.ConclusionPulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit.
Introduction: Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI [greater than or equal to]25 kg/[m.sup.2], and identify response predictors. Methods: A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year. Results: Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5-38.7) kg/[m.sup.2]. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1-2.9), 2.2 (1.8-2.5), and 2.3 (1.9-2.7), p<0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5-3), 1 (0-2), and 1 (0.5-2), p<0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2-5), 0 (0-4.7), and 1.5 (0-4.2), p<0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive. Conclusion: Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit. Keywords: asthma, difficult-to-treat asthma, obesity, pulmonary rehabilitation
Helen Clare Ricketts,1 Varun Sharma,1 Femke Steffensen,2 Elaine Mackay,3 Gordon Wallace MacDonald,4 Duncan S Buchan,5 Michael Lean,6 Rekha Chaudhuri,7 Douglas C Cowan4 1College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; 2Glasgow Clinical Research Facility, Glasgow Royal Infirmary, Glasgow, UK; 3Pulmonary Rehabilitation Team, Glasgow Royal Infirmary, Glasgow, UK; 4Respiratory Department, Glasgow Royal Infirmary, Glasgow, UK; 5Division of Sports and Exercise, University of the West of Scotland, Glasgow, UK; 6School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK; 7Respiratory Department, Gartnavel General Hospital, Glasgow, UKCorrespondence: Douglas C Cowan, Email douglas.cowan@ggc.scot.nhs.ukIntroduction: Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary rehabilitation (PR) showed improved outcomes at 8 weeks. Here we assess immediate and one-year effects of asthma-tailored PR in participants with difficult-to-treat asthma and BMI ≥ 25 kg/m2, and identify response predictors.Methods: A prospective observational study of PR, tailored to asthma, comparing outcomes at baseline (V1), immediately after 8 weeks of PR (V2), and at 1 year (V3). Baseline characteristics were compared in responders/non-responders defined by achievement of minimum clinically important difference (MCID) for asthma control questionnaire (ACQ6) (0.5) at 8 weeks and 1 year.Results: Of 92 participants, 56 attended V2 and 45 attended V3. Mean age was 60 (SD 13) years, 60% were female, and median (IQR) BMI was 33.8 (29.5– 38.7) kg/m2. At V1, V2, and V3, respectively, there were significant differences in ACQ6 (mean (95% CI): 2.5 (2.1– 2.9), 2.2 (1.8– 2.5), and 2.3 (1.9– 2.7), p< 0.003), Borg breathlessness score post-6-minute walk test (median (IQR): 2 (0.5– 3), 1 (0– 2), and 1 (0.5– 2), p< 0.035), and annualised exacerbations requiring prednisolone (median (IQR): 3 (2– 5), 0 (0– 4.7), and 1.5 (0– 4.2), p< 0.003). A total of 27/56 (48%) had improvements >MCID for ACQ6 at V2 and 16 (33%) at V3. Participants with higher ACQ6 scores at baseline (suggesting poorer asthma control) were more likely to achieve MCID. Baseline BMI, within the range studied, was not predictive.Conclusion: Pulmonary rehabilitation induced improvements in asthma-related outcomes including perception of breathlessness, asthma control, and exacerbation frequency at 1 year. Those with poorer baseline asthma control were more likely to benefit.Keywords: asthma, difficult-to-treat asthma, obesity, pulmonary rehabilitation
Audience Academic
Author Chaudhuri, Rekha
Buchan, Duncan
Mackay, Elaine
Cowan, Douglas
Steffensen, Femke
Lean, Michael
MacDonald, Gordon
Sharma, Varun
Ricketts, Helen
Author_xml – sequence: 1
  givenname: Helen
  surname: Ricketts
  fullname: Ricketts, Helen
– sequence: 2
  givenname: Varun
  orcidid: 0000-0003-0183-3090
  surname: Sharma
  fullname: Sharma, Varun
– sequence: 3
  givenname: Femke
  surname: Steffensen
  fullname: Steffensen, Femke
– sequence: 4
  givenname: Elaine
  surname: Mackay
  fullname: Mackay, Elaine
– sequence: 5
  givenname: Gordon
  surname: MacDonald
  fullname: MacDonald, Gordon
– sequence: 6
  givenname: Duncan
  surname: Buchan
  fullname: Buchan, Duncan
– sequence: 7
  givenname: Michael
  surname: Lean
  fullname: Lean, Michael
– sequence: 8
  givenname: Rekha
  surname: Chaudhuri
  fullname: Chaudhuri, Rekha
– sequence: 9
  givenname: Douglas
  orcidid: 0000-0001-7297-9041
  surname: Cowan
  fullname: Cowan, Douglas
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39346093$$D View this record in MEDLINE/PubMed
BookMark eNptkk-L1DAYh4usuOu6J-8SEESQjkmTpulJhvXfyMIMOh48hTR9O82SNmOS7uIX8fOaccZlBkwPCcnzPu3b_J5mZ6MbIcueEzwrCKvefpnPZ98Y56Jmj7ILQiqR85qXZ0fr8-wqhFucBq05p_xJdk5ryjiu6UX2ezEM0BoVAamxRcsR8h-gPFpOUbsBAnJdOkDzEPtB5WtlrPPQotVkBzcq_wt9hV41xpqoonEjWnm38So5kRnR8g78PZhNH_fyBgKgFbitBXRvYo_em64zerIxjy5fe1Dx8KZn2eNO2QBXh_ky-_7xw_r6c36z_LS4nt_kusQs5pRophSvGqExobqsRVHqpiuxhpYzQcqmqCvBClx0WkBLmorjtuI1bilToCi9zBZ7b-vUrdx6M6SepFNG_t1wfiOVj0ZbkLyiotLAqgpzRlQpGK6ToSGkq7VuWHK927u2U5P-qYYxemVPpKcno-nlxt1JQli6kHJneH0wePdzghDlYIIGa9UIbgqSEkIKzAshEvpyj25U-jYzdi4p9Q6Xc0FoSShjdaJm_6HS08JgdEpSZ9L-ScGro4IelI19cHba3W04BV8cN_vQ5b9kJeDNHtDeheChe0AIlrvoyhRdeYgu_QP2_t8G
Cites_doi 10.1007/s11882-021-01024-9
10.1177/0269215519832942
10.1183/13993003.02058-2018
10.1164/rccm.200711-1754OC
10.1097/HCR.0000000000000249
10.1183/13993003.01820-2019
10.1007/s41030-023-00230-2
10.1136/thoraxjnl-2016-209130
10.1183/13993003.01359-2015
10.1136/thoraxjnl-2020-215168
10.1002/14651858.CD013485.pub2
10.3109/02770903.2014.996650
10.1164/rccm.201203-0573OC
10.1183/23120541.00309-2020
10.1186/s12890-022-02152-2
10.1164/rccm.201309-1634ST
10.1016/j.rmed.2019.08.015
10.1136/thorax.57.12.1028
10.1016/j.rmed.2004.10.008
10.1164/ajrccm.166.1.at1102
10.1016/j.rmed.2017.03.029
10.1136/thoraxjnl-2012-203103
10.1016/S0002-9343(00)00472-1
10.1164/rccm.201908-1590ST
10.1016/j.rmed.2007.06.031
10.1164/rccm.200906-0896OC
10.1002/14651858.CD001277.pub4
10.1016/j.rehab.2022.101691
10.1513/AnnalsATS.202111-1228OC
10.1152/ajpregu.00325.2022
10.1136/thoraxjnl-2013-203808
10.1378/chest.118.1.106
10.1164/rccm.9120-11ST
10.1093/ajcn/85.5.1197
10.1183/13993003.congress-2022.579
10.1249/MSS.0000000000001574
ContentType Journal Article
Copyright 2024 Ricketts et al.
COPYRIGHT 2024 Dove Medical Press Limited
2024 Ricketts et al. 2024 Ricketts et al.
Copyright_xml – notice: 2024 Ricketts et al.
– notice: COPYRIGHT 2024 Dove Medical Press Limited
– notice: 2024 Ricketts et al. 2024 Ricketts et al.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.2147/JAA.S466894
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Ricketts et al
EISSN 1178-6965
EndPage 928
ExternalDocumentID oai_doaj_org_article_67387ce4770641a58409a33b11f9ccb4
PMC11439354
A813513449
39346093
10_2147_JAA_S466894
Genre Journal Article
GeographicLocations United Kingdom
GeographicLocations_xml – name: United Kingdom
GrantInformation_xml – fundername: ;
GroupedDBID ---
0YH
29J
2WC
5VS
7RV
8C1
8FE
8FH
8FI
8FJ
8G5
AAYXX
ABUWG
ACGFO
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BKEYQ
BPHCQ
BVXVI
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
EBS
EJD
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
LK8
M2O
M48
M7P
M~E
NAPCQ
O5R
O5S
OK1
P2P
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TDBHL
TR2
UKHRP
VDV
NPM
PJZUB
PPXIY
PQGLB
PMFND
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c504t-31c4aa67b8c013c59825cbf50ced64815b29784202fc8ed1b760d7690d34aea33
IEDL.DBID M48
ISSN 1178-6965
IngestDate Wed Aug 27 01:21:00 EDT 2025
Thu Aug 21 18:31:23 EDT 2025
Thu Sep 04 21:22:00 EDT 2025
Tue Jun 17 22:02:53 EDT 2025
Tue Jun 10 21:00:52 EDT 2025
Thu May 22 21:24:33 EDT 2025
Mon Jul 21 05:40:57 EDT 2025
Tue Jul 01 03:31:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords difficult-to-treat asthma
asthma
pulmonary rehabilitation
obesity
Language English
License https://creativecommons.org/licenses/by-nc/3.0
2024 Ricketts et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c504t-31c4aa67b8c013c59825cbf50ced64815b29784202fc8ed1b760d7690d34aea33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0183-3090
0000-0001-7297-9041
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/JAA.S466894
PMID 39346093
PQID 3111206288
PQPubID 23479
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_67387ce4770641a58409a33b11f9ccb4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11439354
proquest_miscellaneous_3111206288
gale_infotracmisc_A813513449
gale_infotracacademiconefile_A813513449
gale_healthsolutions_A813513449
pubmed_primary_39346093
crossref_primary_10_2147_JAA_S466894
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-01
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-01
  day: 01
PublicationDecade 2020
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
PublicationTitle Journal of asthma and allergy
PublicationTitleAlternate J Asthma Allergy
PublicationYear 2024
Publisher Dove Medical Press Limited
Dove
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Dove
– name: Dove Medical Press
References Dweik (ref27) 2011; 184
Bolton (ref16) 2013; 68
Spruit (ref25) 2013; 188
McDonald (ref9) 2019; 53
ref2
Santino (ref36) 2020; 3
Lista-Paz (ref38) 2023; 66
ref1
Sideleva (ref4) 2012; 186
Freitas (ref21) 2018; 50
Osadnik (ref22) 2022; 8
Hernández (ref34) 2000; 118
Grosbois (ref31) 2019; 157
Moore (ref15) 2010; 181
Casey (ref33) 2013; 68
Sogard (ref39) 2023; 325
Boulet (ref6) 2007; 101
Hudler (ref13) 2023; 9
Troosters (ref35) 2000; 109
Jackson (ref10) 2021; 76
Haldar (ref14) 2008; 178
Agusti (ref8) 2016; 47
Mccarthy (ref17) 2015; 2015
Andreasson (ref37) 2022; 19
Umetsu (ref3) 2017; 72
Klein (ref30) 2007; 85
ref41
Chinn (ref5) 2002; 57
Türk (ref20) 2020; 56
Turk (ref19) 2017; 37
Graham (ref26) 2019; 200
Sharma (ref11) 2023; 60
Arden-Close (ref40) 2019; 33
Ricketts (ref23) 2022; 22
ref28
Sharma (ref7) 2021; 21
Juniper (ref29) 2005; 99
Mesquita (ref32) 2017; 126
Kyriakopoulos (ref12) 2021; 7
Lingner (ref24) 2015; 52
Sahin (ref18) 2019; 56
References_xml – volume: 21
  start-page: 46
  year: 2021
  ident: ref7
  publication-title: Curr Allergy Asthma Rep
  doi: 10.1007/s11882-021-01024-9
– volume: 33
  start-page: 1139
  year: 2019
  ident: ref40
  publication-title: Clin Rehabil
  doi: 10.1177/0269215519832942
– ident: ref1
– volume: 53
  start-page: 1802058
  year: 2019
  ident: ref9
  publication-title: Eur Respir J
  doi: 10.1183/13993003.02058-2018
– volume: 178
  start-page: 218
  year: 2008
  ident: ref14
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200711-1754OC
– volume: 37
  start-page: 214
  year: 2017
  ident: ref19
  publication-title: J Cardiopulm Rehabil Prev
  doi: 10.1097/HCR.0000000000000249
– volume: 56
  start-page: 1901820
  year: 2020
  ident: ref20
  publication-title: Eur Respir J
  doi: 10.1183/13993003.01820-2019
– volume: 9
  start-page: 309
  year: 2023
  ident: ref13
  publication-title: Pulm Ther
  doi: 10.1007/s41030-023-00230-2
– volume: 72
  start-page: 174
  year: 2017
  ident: ref3
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2016-209130
– volume: 47
  start-page: 410
  year: 2016
  ident: ref8
  publication-title: Eur Respir J
  doi: 10.1183/13993003.01359-2015
– volume: 76
  start-page: 220
  year: 2021
  ident: ref10
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2020-215168
– volume: 8
  start-page: 1
  year: 2022
  ident: ref22
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD013485.pub2
– volume: 52
  start-page: 614
  year: 2015
  ident: ref24
  publication-title: J Asthma
  doi: 10.3109/02770903.2014.996650
– volume: 186
  start-page: 598
  year: 2012
  ident: ref4
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201203-0573OC
– volume: 7
  start-page: 00309
  year: 2021
  ident: ref12
  publication-title: ERJ Open Res
  doi: 10.1183/23120541.00309-2020
– volume: 22
  start-page: 363
  year: 2022
  ident: ref23
  publication-title: BMC Pulm Med
  doi: 10.1186/s12890-022-02152-2
– volume: 188
  start-page: e13
  year: 2013
  ident: ref25
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201309-1634ST
– volume: 157
  start-page: 36
  year: 2019
  ident: ref31
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2019.08.015
– volume: 57
  start-page: 1028
  year: 2002
  ident: ref5
  publication-title: Thorax
  doi: 10.1136/thorax.57.12.1028
– volume: 99
  start-page: 553
  year: 2005
  ident: ref29
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2004.10.008
– ident: ref28
  doi: 10.1164/ajrccm.166.1.at1102
– volume: 2015
  start-page: 1
  year: 2015
  ident: ref17
  publication-title: Cochrane Database Syst Rev
– ident: ref2
– volume: 126
  start-page: 122
  year: 2017
  ident: ref32
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2017.03.029
– volume: 68
  start-page: 922
  year: 2013
  ident: ref33
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2012-203103
– volume: 56
  start-page: 87
  year: 2019
  ident: ref18
  publication-title: J Asthma off J Assoc Care Asthma
– volume: 109
  start-page: 207
  year: 2000
  ident: ref35
  publication-title: Am J Med
  doi: 10.1016/S0002-9343(00)00472-1
– volume: 200
  start-page: E70
  year: 2019
  ident: ref26
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201908-1590ST
– volume: 101
  start-page: 2240
  year: 2007
  ident: ref6
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2007.06.031
– volume: 181
  start-page: 315
  year: 2010
  ident: ref15
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200906-0896OC
– volume: 3
  start-page: CD001277
  year: 2020
  ident: ref36
  publication-title: Cochrane Database Syst Rev
  doi: 10.1002/14651858.CD001277.pub4
– volume: 66
  start-page: 101691
  year: 2023
  ident: ref38
  publication-title: Ann Phys Rehabil Med
  doi: 10.1016/j.rehab.2022.101691
– volume: 19
  start-page: 1498
  year: 2022
  ident: ref37
  publication-title: Ann Am Thorac Soc
  doi: 10.1513/AnnalsATS.202111-1228OC
– volume: 325
  start-page: R645
  year: 2023
  ident: ref39
  publication-title: Am J Physiol-Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00325.2022
– volume: 68
  start-page: 1
  year: 2013
  ident: ref16
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2013-203808
– volume: 60
  start-page: 385
  year: 2023
  ident: ref11
  publication-title: J Asthma off J Assoc Care Asthma
– volume: 118
  start-page: 106
  year: 2000
  ident: ref34
  publication-title: Chest
  doi: 10.1378/chest.118.1.106
– volume: 184
  start-page: 602
  year: 2011
  ident: ref27
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.9120-11ST
– volume: 85
  start-page: 1197
  year: 2007
  ident: ref30
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/85.5.1197
– ident: ref41
  doi: 10.1183/13993003.congress-2022.579
– volume: 50
  start-page: 1367
  year: 2018
  ident: ref21
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/MSS.0000000000001574
SSID ssj0000396636
Score 2.279386
Snippet Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled trial of pulmonary...
Introduction: Management of difficult-to-treat asthma is particularly challenging in people with elevated body mass index (BMI). Our randomised controlled...
Helen Clare Ricketts,1 Varun Sharma,1 Femke Steffensen,2 Elaine Mackay,3 Gordon Wallace MacDonald,4 Duncan S Buchan,5 Michael Lean,6 Rekha Chaudhuri,7 Douglas...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 911
SubjectTerms Asthma
Body mass index
Comparative analysis
Corticosteroids
difficult-to-treat asthma
obesity
Original Research
Patient compliance
Prednisolone
pulmonary rehabilitation
Rehabilitation
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZQDxUXRHkuLWCkSpyWbtb2Po5boCqVIBGkUjlZfqqRyKZqNof-EX4vM_Y2isWBC9f1KFn7G3tmvDPfEHLsDLde1EVelspCgOLhHBTe5sIIrU2jkI8Esy2-VeeX_OJKXO20-sKcsEgPHBfuBLtS1sbxugbjOVECAxLFmJ5MfGuMDkygRVvsBFPhDGbgxuN3SSzIw1Y8Jxdd9-EHr6qm5YkJCkz9f5_HOwYpTZbcsT5nj8mj0W2kXXzdA_LA9U_I_tfxw_hT8vvLMtSADI6q3tJp7_KfoMN0uhlApdyarjwM0G49XC9VPlcLCNOdpbPNL1BDdXtHvyeM3XQW07aWji56Og3J0xjFxx_Xbu3oLKSeU7zHpZ_w4gc5PPJhlc_RDR3_6Rm5PPs8_3iejy0XciMKPsCJbLhSVa0bA76hQXY_YbQXhXG2Ql4XXULYycui9KZxdqLrqrA1RNiWceUAl-dkr1_17iWhADIzpS8bJTz4ZLDwdVlpkGkrz1vjM3J8j4K8icwaEiISBEsCWHIEKyOniNBWBOmwwwNQEjkqifyXkmTkLeIrY23pdlPLrsEGhYzzNiPvgwRua4DZqLE6AeaCBFmJ5FEiCdvRJMPv7nVI4hDmsPVutVlLBmalDO2dM_Ii6tR2VqxlvCpalpEm0bZk2ulIv7gObOAQ0GJ5NX_1PxbqkDwEbHm8Yzoie8Ptxr0Gr2vQb8IG-wOhDio4
  priority: 102
  providerName: Directory of Open Access Journals
Title Immediate and One-Year Outcomes of an Asthma-Tailored Pulmonary Rehabilitation Programme in Overweight and Obese People with Difficult-to-Treat Asthma
URI https://www.ncbi.nlm.nih.gov/pubmed/39346093
https://www.proquest.com/docview/3111206288
https://pubmed.ncbi.nlm.nih.gov/PMC11439354
https://doaj.org/article/67387ce4770641a58409a33b11f9ccb4
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELf2ISFeEIyPBUYx0iSeMpLYzscDQtnYVCaxVqOVtqfIdmxWaU2gTSX2j_D3cuek1SL2xEse6ktS53dn39nn3xFyaDQvrUgCP4pkCQGKhXFQ2NIXWiilU4l8JJhtcREPp_z8SlxtkXUxzu4DLh8M7bCe1HRxe_T7191nMPhPmMYc8uTjeZ4ffedxnGZ8m-y6jSLM4ev8fDckM_DqcZty74F7ejOSI-7_d3i-Nz_1cyfvTUZnT8mTzoukeQv7M7Jlqj3y6Fu3T_6c_Pk6d0dCGkNlVdJRZfxrUGk6WjWgYWZJawsNNF82N3PpT-QMonZT0vHqFrRSLu7oZY_Am47bLK65obOKjlwuNQb17cOVWRo6dpnoFJd16RdcB0JKD7-p_Ql6pd2bXpDp2enkZOh3FRh8LQLewACtuZRxolINrqJGsj-hlRWBNmWMNC8qgiiUR0FkdWrKUCVxUCYQcJeMSyMZe0l2qroy-4QC5kxHNkqlsOCiwYdPoliBTBZbnmnrkcM1CsXPlmijgAAFwSoArKIDyyPHiNBGBNmx3Q_14kfRGRvmqqWJNjxJwOEKpcAgFv6MCkObaa3gIe8Q36I9arqx8SJPsV4h4zzzyAcngXoHMGvZHVaAviBfVk_yoCcJ1ql7ze_XOlRgE6a0VaZeLQsGs0zkqj175FWrU5tesYzxOMiYR9KetvW63W-pZjeOHBziWzxtzV___61vyGNAlLcLTQdkp1mszFtwvRo1INvB9RCu6Uk4ILvHpxfjy4Fbxhg4g_sL0Pk0vw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immediate+and+One-Year+Outcomes+of+an+Asthma-Tailored+Pulmonary+Rehabilitation+Programme+in+Overweight+and+Obese+People+with+Difficult-to-Treat+Asthma&rft.jtitle=Journal+of+asthma+and+allergy&rft.au=Ricketts%2C+Helen+Clare&rft.au=Sharma%2C+Varun&rft.au=Steffensen%2C+Femke&rft.au=Mackay%2C+Elaine&rft.date=2024-01-01&rft.pub=Dove&rft.eissn=1178-6965&rft.volume=17&rft.spage=911&rft.epage=928&rft_id=info:doi/10.2147%2FJAA.S466894&rft.externalDocID=PMC11439354
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-6965&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-6965&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-6965&client=summon